Adverse Event Reporting Hotline Being Refined Through FDA Labeling Study

FDA is honing in on the wording for the adverse event statement to be included on labeling as part of the agency's proposed rule to add a toll-free number to the MedWatch adverse event reporting system

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet